NPR – Share prices for the British drugmaker Indivior plunged today on the London Stock Exchange. The drop came on news that the U.S. Justice Department indicted the company on fraud and conspiracy charges.
Marketing
Do Firms Use Brands to Circumvent Regulatory Requirements?
Have large financial companies secretly circumvented government regulations designed to safeguard vulnerable investors from bad decision-making?Continue Reading
Do Firms Use Brands to Circumvent Regulatory Requirements?
Have large financial companies secretly circumvented government regulations designed to safeguard vulnerable investors from bad decision-making? Continue Reading
XFL still working to clinch TV deal
Waterbury Hosts Business and Human Rights Lecture Series
Former Timex executive Bob Werner will be the keynote speaker during the second of a three-part lecture series on business and human rights, hosted at the UConn Waterbury campus. Continue Reading
Vineyard Vines to Launch Target Collection
Many sue OxyContin maker, but not its own city: Stamford
Opioids: Boston trial opens what could be year of reckoning for executives
The Quest for Joy
Medium – A Q&A with Professor Robin Coulter about Marie Kondo, the psychology of clutter, and what it means for marketers.
Purdue Pharma to research non-opioid treatments
Daily Heralds – Purdue Pharma, the controversial maker of OxyContin, and eyecare-pharmaceutical firm Ocular Therapeutix has announced a research partnership aiming to develop non-opioid pain treatments.
Read article